Candel Therapeutics (CADL) Shares Outstanding (2020 - 2025)

Candel Therapeutics' Shares Outstanding history runs 6 years deep, the most recent figure standing at $54.9 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 17.28% year-over-year to $54.9 million; the TTM figure through Dec 2025 stood at $54.9 million (up 17.28% YoY), while the FY2025 annual figure was $54.9 million, up 17.28% from the prior year.
• Shares Outstanding came in at $54.9 million for Q4 2025 at Candel Therapeutics, roughly flat from $55.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $55.0 million in Q2 2025 to a low of -$122608.0 in Q3 2022.
• A 5-year average of $27.5 million and a median of $29.0 million in 2022 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding slumped 100.43% in 2022 and jumped 24136.01% in 2024, its largest moves.
• Candel Therapeutics' Shares Outstanding stood at $28.7 million in 2021, then plunged by 100.43% to -$122608.0 in 2022, then surged by 23926.85% to $29.2 million in 2023, then jumped by 60.24% to $46.8 million in 2024, then gained by 17.28% to $54.9 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $54.9 million, $55.0 million, and $55.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison